As the Republic of Congo advances its public health initiatives, the integration of synbiotic formulations—combining probiotics and prebiotics—represents a paradigm shift. In Central African markets, nutritional security is transitioning from mere calorie intake to "functional optimization." Our Shanghai Aeterna Biotech facility provides the high-potency, heat-stable strains specifically designed to maintain viability in tropical climates.
The Republic of Congo’s healthcare sector is increasingly focusing on preventative digestive medicine. Given the local dietary habits, our Xylo-Oligosaccharides (XOS) are particularly suited to stabilize gut flora and boost immune resilience. We are currently scouting partnerships with local pharmaceutical distributors in Brazzaville and Pointe-Noire to bring premium-grade OEM capsules to the population.
We leverage China’s advanced logistics efficiency to overcome geographical hurdles. Our "Quality Assurance/Quality Control" (QA/QC) protocol ensures that every batch of Lactobacillus Acidophilus (200 Billion CFU/g) withstands rigorous transit conditions, guaranteeing clinical-grade potency upon arrival in the Congo.
Yes, we utilize advanced micro-encapsulation technology that stabilizes probiotics, ensuring high survival rates even in high-humidity tropical environments.
We offer flexible, scalable solutions suitable for emerging brands in the Republic of Congo. Contact us for custom quotes.
Aeterna Biotech
